Literature DB >> 23032134

Predictors of quality of life in patients with refractory mesial temporal lobe epilepsy.

Carla Pauli1, Maria Emilia de Oliveira Thais, Lucia Sukys Claudino, Maria Alice Horta Bicalho, Alexandre Cunha Bastos, Ricardo Guarnieri, Jean Costa Nunes, Katia Lin, Marcelo Neves Linhares, Roger Walz.   

Abstract

PURPOSE: The identification of variables associated with health-related quality of life (HRQoL) in patients with mesial temporal lobe epilepsy related to hippocampal sclerosis (MTLE-HS) would improve surgical decision-making and post-operatory follow-up in this group of patients.
METHODS: We analyzed the independent association between the Quality of Life in Epilepsy Inventory-31 (QOLIE-31) of 81 consecutive patients with refractory MTLE-HS. The clinical, demographic, radiological and electrophysiological variables were analyzed by multiple linear regression analysis. KEY
FINDINGS: Approximately 36% (adjusted R(2)=0.36; R coefficient=0.66) of the QOLIE-31 overall score variance was explained by the history of initial precipitant injury, family history of epilepsy, disease duration, age of epilepsy onset, seizure frequency and presence of psychiatric axis-II diagnosis. The variance of QOLIE-31 sub-scales was: seizure worry=7%; overall QOL=11%; emotional well-being=32%; energy/fatigue=38%; cognitive function=13%; medication effects=7%; social function=13% (R coefficient between 0.30 and 0.65). SIGNIFICANCE: The pre-surgical variables studied had relatively low prediction capacity for the overall QOLIE-31 score and its sub-scales in this set of Brazilian patients with refractory MTLE-HS.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23032134     DOI: 10.1016/j.yebeh.2012.06.037

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  7 in total

1.  Amygdala levels of the GluA1 subunit of glutamate receptors and its phosphorylation state at serine 845 in the anterior hippocampus are biomarkers of ictal fear but not anxiety.

Authors:  Rodrigo Bainy Leal; Mark William Lopes; Douglas Affonso Formolo; Cristiane Ribeiro de Carvalho; Alexandre Ademar Hoeller; Alexandra Latini; Daniel Santos Sousa; Peter Wolf; Rui Daniel Prediger; Zuner Assis Bortolotto; Marcelo Neves Linhares; Kátia Lin; Roger Walz
Journal:  Mol Psychiatry       Date:  2018-06-07       Impact factor: 15.992

2.  Decision Making in Adrenoleukodystrophy: When Is a Good Outcome Really a Good Outcome?

Authors:  Keith Van Haren; Marc Engelen
Journal:  JAMA Neurol       Date:  2017-06-01       Impact factor: 18.302

3.  Mitochondrial Respiration Chain Enzymatic Activities in the Human Brain: Methodological Implications for Tissue Sampling and Storage.

Authors:  Marcelo Fernando Ronsoni; Aline Pertile Remor; Mark William Lopes; Alexandre Hohl; Iris H Z Troncoso; Rodrigo Bainy Leal; Gustavo Luchi Boos; Charles Kondageski; Jean Costa Nunes; Marcelo Neves Linhares; Kátia Lin; Alexandra Susana Latini; Roger Walz
Journal:  Neurochem Res       Date:  2015-11-19       Impact factor: 3.996

4.  What are the predictors of quality of life of people with epilepsy?

Authors:  Dana Brabcova; Jiri Kohout
Journal:  J Neurosci Rural Pract       Date:  2013-08

5.  Clinical predictors of 2-year outcome of resective epilepsy surgery in adults with refractory epilepsy: a cohort study.

Authors:  B Kanchanatawan; C Limothai; T Srikijvilaikul; M Maes
Journal:  BMJ Open       Date:  2014-04-22       Impact factor: 2.692

6.  A single high dose of dexamethasone affects the phosphorylation state of glutamate AMPA receptors in the human limbic system.

Authors:  M W Lopes; R B Leal; R Guarnieri; M L Schwarzbold; A Hoeller; A P Diaz; G L Boos; K Lin; M N Linhares; J C Nunes; J Quevedo; Z A Bortolotto; H J Markowitsch; S L Lightman; R Walz
Journal:  Transl Psychiatry       Date:  2016-12-13       Impact factor: 6.222

7.  Quality of life and its associated factors among epileptic patients attending public hospitals in North Wollo Zone, Northeast Ethiopia: A cross-sectional study.

Authors:  Ayelign Mengesha Kassie; Biruk Beletew Abate; Mesfin Wudu Kassaw; Addisu Getie; Adam Wondmieneh; Kindie Mekuria Tegegne; Mohammed Ahmed
Journal:  PLoS One       Date:  2021-02-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.